Stock data
OS Therapies Incorporated (OSTX)
OS Therapies Incorporated (OSTX) reported net income of -US$28.75M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$28.71M | -US$28.75M | — |
| 2024 | — | — | -US$6.81M | -US$8.88M | — |
| 2023 | — | — | -US$4.34M | -US$7.79M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$8.63M | — |
| 2026-03-31 | — | -US$10.40M | — |
| 2025-12-31 | — | -US$13.46M | — |
| 2025-09-30 | — | -US$6.88M | — |
| 2025-06-30 | — | -US$4.54M | — |
| 2025-03-31 | — | -US$3.88M | — |
| 2024-12-31 | — | -US$2.99M | — |
| 2024-09-30 | — | -US$2.88M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.